Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-04

Clinical Trial Update: Effect of Acetazolamide and Furosemide on Obesity-induced Glomerular Hyperfiltration [NA]

View source ↗

Summary

This completed clinical study evaluated whether acetazolamide and furosemide affect obesity-induced glomerular hyperfiltration, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)
  • FUROSEMIDE (Furosemide)

Snippet

Sponsor: Rabin Medical Center | Conditions: Obesity-induced Hyperfiltration | NA | Status: COMPLETED | Results posted: 2015-06-04